FREMONT, Calif., April 19 /PRNewswire-FirstCall/ -- Vermillion, Inc. today announced the appointment of Sandra A. Gardiner as Vice President and Chief Financial Officer (CFO). In her role as CFO, Ms. Gardiner will be responsible for leading all aspects of financial management for Vermillion.
Ms. Gardiner joins Vermillion from Bend Research Inc. where she served as Chief Financial Officer since March 2009 and was elected to their board of directors in April 2009. From 2004 through 2008 she served as Chief Financial Officer and Corporate Secretary of Lipid Sciences, Inc., responsible for all decision-making authority for all financial and administrations functions for this development-stage biotechnology company, which is engaged in research and development of products and processes to treat cardiovascular disease and viral infections. She also held positions at Cardima, Inc. and Comac and began her biotechnology career in 1988 with Advanced Cardiovascular Systems, formerly a division of Guidant, holding several positions in the Internal Audit, Accounting and Finance departments. Ms. Gardiner received her Bachelor of Science in Managerial Economics from the University of California at Davis.
About Vermillion
About OVA1
Forward-Looking Statement
CONTACT: Jill Totenberg, for Vermillion, +1-212-994-7363, or
+1-917-697-6900, jt@totenberggroup.com
Web site: http://www.vermillion.com/
